Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering
Nucleic Acids Research · 27.10.2023 · 51 (19) · 10147-10161
DOI: 10.1093/nar/gkad736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.09.2023. Verfasst von Jaclyn M Noshay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Computational and Predictive Biology, Biosciences, Oak Ridge National Laboratory, Oak Ridge, TN, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biological and Environmental Research, Office of Biological and Environmental Research in the DOE Office of Science, U.S. Department of Energy.
Abstract (Originalsprache)
CRISPR-Cas9 tools have transformed genetic manipulation capabilities in the laboratory. Empirical rules-of-thumb have been developed for only a narrow range of model organisms, and mechanistic underpinnings for sgRNA efficiency remain poorly understood. This work establishes a novel feature set and new public resource, produced with quantum chemical tensors, for interpreting and predicting sgRNA efficiency. Feature engineering for sgRNA efficiency is performed using an explainable-artificial intelligence model: iterative Random Forest (iRF). By encoding quantitative attributes of position-specific sequences for Escherichia coli sgRNAs, we identify important traits for sgRNA design in bacterial species. Additionally, we show that expanding positional encoding to quantum descriptors of base-pair, dimer, trimer, and tetramer sequences captures intricate interactions in local and neighboring nucleotides of the target DNA. These features highlight variation in CRISPR-Cas9 sgRNA dynamics between E. coli and H. sapiens genomes. These novel encodings of sgRNAs enhance our understanding of the elaborate quantum biological processes involved in CRISPR-Cas9 machinery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Computational and Predictive Biology, Biosciences, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
- Bredesen Center for Interdisciplinary Research and Graduate Education, University of Tennessee-Knoxville, Knoxville, TN, USA.
- Synthetic Biology, Biosciences,Oak Ridge National Laboratory, Oak Ridge, TN, USA.
- Computational Sciences and Engineering, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
ORCID-Profile: Jaclyn M Noshay, David Kainer, Daniel A Jacobson
Förderung
- Biological and Environmental Research
- Office of Biological and Environmental Research in the DOE Office of Science
- U.S. Department of Energy
- U.S. Department of Energy, Office of Science, through the Genomic Science Program, Office of Biological and Environmental Research
- Office of Science of the U.S. Department of Energy
Zitieren
APA
Noshay, J. M., Walker, T., Alexander, W. G., Klingeman, D. M., Romero, J., Walker, A. M., Prates, E., Eckert, C., Irle, S., Kainer, D., & Jacobson, D. A. (2023). Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering. Nucleic Acids Research, 51(19), 10147-10161. https://doi.org/10.1093/nar/gkad736
Vancouver
Noshay JM, Walker T, Alexander WG, Klingeman DM, Romero J, Walker AM, et al. Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering. Nucleic Acids Research. 2023;51(19):10147-10161. doi:10.1093/nar/gkad736
BibTeX
@article{Noshay2023,
author = {Noshay, Jaclyn M and Walker, Tyler and Alexander, William G and Klingeman, Dawn M and Romero, Jonathon and Walker, Angelica M and Prates, Erica and Eckert, Carrie and Irle, Stephan and Kainer, David and Jacobson, Daniel A},
title = {Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {19},
pages = {10147--10161},
doi = {10.1093/nar/gkad736}
}
EUVIMED